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One important problem in genomic research is to identify genomic features such
as gene expression data or DNA single nucleotide polymorphisms (SNPs) that are
related to clinical phenotypes. Often these genomic data can be naturally divided
into biologically meaningful groups such as genes belonging to the same path-
ways or SNPs within genes. In this paper, we propose group additive regression
models and a group gradient descent boosting procedure for identifying groups of
genomic features that are related to clinical phenotypes. Our simulation results
show that by dividing the variables into appropriate groups, we can obtain better
identification of the group features that are related to the phenotypes. In addition,
the prediction mean square errors are also smaller than the component-wise boost-
ing procedure. We demonstrate the application of the methods to pathway-based
analysis of microarray gene expression data of breast cancer and gene-based ge-
netic association analysis of type 1 diabetes. Results from analysis of two breast
cancer data sets indicate that the pathways of Metalloendopeptidases (MMPs) and
MMP inhibitors, as well as cell proliferation, cell growth and maintenance are im-
portant to breast cancer relapse and survival. Results from analysis of a set of non-
synonymous SNPs on chromosome 6 confirmed a few genes that are associated
with type 1 diabetes.
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Abstract
One important problem in genomic research is to identify genomic features such as gene
expression data or DNA single nucleotide polymorphisms (SNPs) that are related to clinical
phenotypes. Often these genomic data can be naturally divided into biologically meaning-
ful groups such as genes belonging to the same pathways or SNPs within genes. In this
paper, we propose group additive regression models and a group gradient descent boosting
procedure for identifying groups of genomic features that are related to clinical phenotypes.
Our simulation results show that by dividing the variables into appropriate groups, we can
obtain better identification of the group features that are related to the phenotypes. In ad-
dition, the prediction mean square errors are also smaller than the component-wise boosting
procedure. We demonstrate the application of the methods to pathway-based analysis of
microarray gene expression data of breast cancer and gene-based genetic association anal-
ysis of type 1 diabetes. Results from analysis of two breast cancer data sets indicate that
the pathways of Metalloendopeptidases (MMPs) and MMP inhibitors, as well as cell prolif-
eration, cell growth and maintenance are important to breast cancer relapse and survival.
Results from analysis of a set of nonsynonymous SNPs on chromosome 6 confirmed a few
genes that are associated with type 1 diabetes.
Keywords: Linear models, Accelerated failure time models, Variable importance, Microar-
ray, Single nucleotide polymorphisms, Boosting.
1 Introduction
New high-throughput technologies are generating various high-dimensional genomic data for
investigating complex biological systems and complex phenotypes. These data also provide an
opportunity for identifying pathways and genes that are related to various clinical phenotypes.
One great challenge in studying the relationship between genomic data and phenotypes is to deal
1
http://biostats.bepress.com/upennbiostat/art12
with the high-dimensionality of such data. The “curse of dimensionality” makes most traditional
statistical methods unsuitable or inefficient for analyzing such genomic data. However, it is
important to note that although the genomic data are high-dimensional, they are intrinsically
low dimensional, implying that we should expect a small number of genes that are related to
the phenotype of interest. In addition, many high-dimensional genomic data can be naturally
grouped into small sets based on current biological knowledge. For example, when analyzing
microarray gene expression data, one can group genes into functionally similar sets as in Gene
Ontology (GO) (2000) or into known biological pathways such as the KEGG pathways (Kanehisa
and Goto, 2002). The gene expression levels of these genes can be used to characterize the activity
levels of the pathways, which may in turn affect the phenotypes. When one analyzes large-scale
SNP data, one can group the SNPs within the intragenic and regulatory regions of a given gene
into a group and perform gene-based association analysis (Neale and Sham, 2004). The SNPs
within a gene can be used to characterize the functionality of this gene. The focus of this paper
is to develop group additive regression (GAR) models for identifying these groups of the genomic
variables related to complex phenotypes.
Methods from machine learning or statistical learning literature have gained great popularity
in analysis of genomic data, especially microarray gene expression data. Among these, boosting
(Freund, 1995; Freund and Schapire, 1996) and random forest (Breiman, 2001) are the two most
successful and practical methods and have been demonstrated to perform well in building predic-
tive models using high-dimensional genomic data (Dettling and Bu¨hlmann, 2003; Li and Luan,
2005; Wei and Li, 2006). Friedman, Hastie and Tibshirani (2000) made an insightful connec-
tion between boosting and additive logistic regression modeling and showed that the boosting
procedure is an optimization method for finding a classifier minimizing a particular exponen-
tial loss function in the framework of additive modeling. Friedman (2001) proposed a general
gradient descent boosting (GDBoosting) framework which can be applied to various regression
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models. Focusing on regression and L2 loss functions, Bu¨hlmann and Yu (2003) proposed a
novel component-wise boosting procedure based on cubic smoothing splines or least squares
and demonstrated its effectiveness in the presence of high-dimensional predictors. Recently,
Bu¨hlmann (2006) proposed a component-wise L2 boosting procedure in a high-dimensional lin-
ear model setup and proved a consistent result on prediction; allowing the predictors to grow
exponentially faster than the sample sizes under the sparsity conditions.
In order to take into account and to utilize the group structure of the genomic data and to
utilize prior biological knowledge, Wei and Li (2006) proposed a nonparametric pathway-based
regression model and a modification of the GDBoosting procedure in order to identify pathways
that are related to clinical phenotypes, where they used regression trees (Breiman and others,
1984) as base learners. Although trees are very flexible in modeling potential interactions among
the variables, the resulting model from GDBoosting is a linear combination of many small trees,
which can be difficult to interpret in terms of variable importance. In this paper, we propose a
group gradient descent boosting (G-GDBoosting) procedure for identifying groups of variables
that are related to the phenotypes in the framework of GAR models using least squares or
regularized least squares as base learners. Such a procedure results in GAR models with explicit
expressions of the estimators and a natural way of defining the importance of a group of variables
to the phenotypes. Such importance scores can then be applied to rank the importance of the
groups of variables in a regression modeling framework.
The rest of the paper is organized as follows. We first introduce the GAR models. We then
present the G-GDBoosting procedure for fitting the GAR models. We present simulation studies
to evaluate the methods and to compare the results with the component-wise boosting procedure.
We also present results from analysis of several real genomic data sets. Finally, we present a
brief discussion of the results and methods.
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2 Group Additive Regression Models
Suppose that there is a total of p genomic variables that can be divided into K groups whose
activities might be related to the phenotype of interest. We allow some variables to belong
to multiple groups. Here the groups can be different pathways or functional sets when the
variables are the gene expression levels. The groups can also be genes where SNPs with genes
are the respective variables. Let the vector x = (x1, x2, . . . , xp)
T represent all the p variables,
where the superscript T represents the transpose. Let the kth group have pk variables, denoted
by {xk1, xk2, . . . , xkpk}, where {k1, k2, . . . , kpk} ⊂ {1, 2, . . . , p}. Note that p ≤
∑K
k=1 pk. Let
x(k) = (xk1, xk2, . . . , xkpk)
T , k = 1, . . . , K be the vector of the genomic data and y represent the
phenotype.
We assume that the phenotype, y, is related to the genomic data x by through the following
GAR model,
y =
K∑
k=1
Fk(x(k)) + ² (1)
where ² is the noise term, Fk(x(k)) is the group effect as determined by the genomic data x(k) of
the kth group. This model assumes additive effects of different groups on the phenotype y. One
simple GAR model is to assume that Fk(x(k)) is modeled as a linear model,
Fk(x(k)) =
K∑
k=1
βTk x(k) (2)
where βk is a vector of coefficients corresponding to the genomic data in the group k. Alterna-
tively, in order to model the interactions of genomic data within a group, we can assume the
following model for Fk(x(k)),
Fk(x(k)) =
pk∑
l=1
βklxkl +
∑
l 6=l′
βkll′xklxkl′ (3)
where βkll′ measures the interaction effect between two genomic features within the kth group.
In analysis of real data sets, when K is large, we should expect sparsity of the models, i.e., we
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should expect that many of Fk(x(k)) should be zero. The question is how to identify the groups
with Fk(x(k)) 6= 0.
3 A Group Gradient Descent Boosting Procedure with
Least Square as Weak Learners
Suppose that we have n i.i.d. samples. Let yi represent the phenotype, x
(i) = (x
(i)
1 , x
(i)
2 , . . . , x
(i)
p )T
represent the genomic measurements for the ith individual and let x
(i)
(k) = (x
(i)
k·1, x
(i)
k·2, . . . , x
(i)
k·pk)
T
be the genomic measurements in the kth group for the ith individual. The sample data set
{yi, x(i)}ni=1 follows the GAR model,
yi = F (x
(i)) + ²i, i = 1, . . . , n,
where {²i, i = 1, . . . , n} are noises and F (x(i)) =
∑K
k=1 β
T
k x
(i)
(k). We first introduce the following
notation:
XT(k) =
(
x
(1)
(k), . . . , x
(n)
(k)
)
, a matrix of pk by n, k = 1, . . . , K,
X =
(
X(1), . . . , X(K)
)
, a matrix of n by
K∑
k=1
pk,
Y = (y1, . . . , yn)
T , an n−dimensional vector,
² = (²1, . . . , ²n)
T , an n−dimensional vector,
H(k) = X(k)
(
XT(k)X(k)
)−1
XT(k), a square matrix of order n, k = 1, . . . , K,
B(k) =
(
XT(k)X(k)
)−1
XT(k), a matrix of pk by n, k = 1, . . . , K.
It is easy to see that H(k) and B(k) are projection matrices and “hat” matrices determined by the
variables in the kth group. Based on these notations, we present the following group gradient
descent boosting (G-GDBoosting) algorithm:
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A Group Gradient Descent Boosting Algorithm
Initialization. Set m← 0, and βˆ(m)k = βˆ(0)k = 0, k = 1, . . . , K. Consequently,
Fˆ (m)(x) = Fˆ (0)(x) =
K∑
k=1
(
βˆ
(0)
k
)T
x(k) = 0,
Yˆ (m) = Yˆ (0) =
(
Fˆ (0)(x(1)), . . . , Fˆ (0)(x(n))
)T
= 0,
Uˆ (m) = Uˆ (0) = Y − Yˆ (0) = Y.
Step 1. Select an index, im ∈ {1, . . . , K}, such that the imth group mostly explains the current
residual Uˆ (m) by linear regression. More specifically, im is chosen by the following equation,
im = argmin1≤k≤K‖Uˆ (m) −H(k)Uˆ (m)‖2,
where ‖ · ‖ represents the conventional Euclidean L2 norm.
Step 2. Update the current estimates of coefficient vectors {βˆ(m)1 , . . . , βˆ(m)K },
βˆ
(m+1)
k = βˆ
(m)
k , k 6= im, βˆ(m+1)im = βˆ(m)im + ρBimUˆ (m),
where ρ is the learning rate.
Step 3. Continue the updates,
Fˆ (m+1)(x) = Fˆ (m)(x) + ρBimUˆ
(m)x(im) =
K∑
k=1
(
βˆ
(m+1)
k
)T
x(k),
Yˆ (m+1) =
(
Fˆ (m+1)(x(1)), . . . , Fˆ (m+1)(x(n))
)T
,
Uˆ (m+1) = Y − Yˆ (m+1).
Step 4. Set m← m+ 1, go to Step 1 unless m+ 1 =M . The final estimate is
Fˆ (M)(x) =
K∑
k=1
(
βˆ
(M)
k
)T
x(k).
This algorithm is a special case of the general gradient descent boosting procedure of Friedman
(2001). The key difference is in Step 1, where instead of all the variables being used to build
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the base learners as in Friedman (2001), we build the base learners using only the variables
within the groups and select the group that fits the residuals the best. At each boosting step, at
most one new group is added to the model; the algorithm can, therefore, be used to select the
relevant groups. In addition, if all the groups include only one variable, the algorithm becomes
the component-wise boosting algorithm proposed in Bu¨hlmann (2006). Since the base learners
are linear, it can be easily verified that the following recursive formula holds for Yˆ (m) and βˆ
(m)
k
at the mth boosting step:
Yˆ (m) = AˆmY,
βˆ
(m)
k = Dˆ
(m)
k Y,
for k = 1, . . . , K, m = 0, . . . ,M , where {Aˆm, Dˆ(m)k , k = 1, . . . , K}Mm=0 are given by the following
recursive formula,
Aˆ0 = 0, Aˆm = I − (I − ρHi0) · · ·
(
I − ρHim−1
)
, m = 1, . . . ,M,
Dˆ
(0)
k = 0, k = 1, . . . , K,
Dˆ
(m)
k = Dˆ
(m−1)
k , k 6= im−1, k = 1, . . . , K,
Dˆ
(m)
k = Dˆ
(m−1)
k + ρBim−1
(
I − Aˆm−1
)
, k = im−1, m = 1, . . . ,M,
where I is the identity matrix of order n. Based on this recursive formula, for a chosen indices
{i0, i1, . . . , im−1}, we have the following expression for the hat matrix,
Dˆ
(m)
k =
∑
{l: 0≤l≤m−1,il=k}
ρBk
(
I − Aˆl
)
, k = 1, . . . , K, m = 1, . . . ,M.
This hat matrix is used to define the effective degrees of freedom of the associated boosting
procedure used in our AIC definition (see Section 3.2).
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3.1 Group gradient descent boosting with penalized least squares as
base learners
The G-GDBoosting procedure with least squares as weak learners involves the inverse of matrix(
XT(k)X(k)
)
. If the number of variables in some groups is larger than the sample size, or the
variables within one group are highly correlated,
(
XT(k)X(k)
)
can be singular or near singular, so
the previous algorithm cannot be applied directly. To mediate this problem, we propose to apply
a ridge regression or penalized least square regression in place of the ordinary least regressions
as base learners in the proposed G-GDBoosting procedure. More specifically, we re-define the
matrices H(k) and B(k) used in the G-GDBoosting procedure as the following:
H
(λ)
(k) = X(k)
(
XT(k)X(k) + λI
)−1
XT(k), a square matrix of order n, k = 1, . . . , K,
B
(λ)
(k) =
(
XT(k)X(k) + λI
)−1
XT(k), a matrix of pk by n, k = 1, . . . , K,
where I is an identity matrix and λ is a tuning parameter for L2 penalized estimation. The
G-GDboosting algorithm remains the same as that presented in a previous section with H(k) and
B(k) being replaced by H
(λ)
(k) and B
(λ)
(k) .
3.2 Criteria for stopping the boosting iterations
Boosting needs to stop at a suitable number of iterations to avoid overfitting. One approach
is to use cross-validation to find the best step number m that yields the best prediction result.
Alternatively, the trace of the boosting hat matrix Aˆm can be interpreted as the degree of freedom
of the resulting estimator and a corrected AIC (Hurvich et al., 1998) score function of m can be
defined as
AIC(m) = log(σˆ2) +
1 + trace(Aˆm)/n
1− (trace(Aˆm) + 2)/n
,
σˆ2 = n−1‖Y − Yˆ (m)‖2 = n−1‖Uˆ (m)‖2.
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Given a large positive integer M0, an estimate of the stopping iteration step number can be
chosen as
Mˆ = argmin{1≤m≤M0}AIC(m).
In the case when the penalized least squares are used as base learners, the AIC score function
depends on two arguments: m and λ in L2 regularization. Consequently, the estimate of the
best stopping iteration step becomes
Mˆ = argmin{1≤m≤M0, 0≤λ}AIC(m,λ).
3.3 Selection of relevant groups
As noted in a previous section, at each of the boosting steps, the G-GDBoosting algorithm either
updates the groups selected or adds a new group to the model. The groups that are selected by
the algorithm should in general be relevant or important to the phenotypes. We present in the
following a quantitative measurement of the importance of the selected groups to the phenotype.
Based on the simple closed form estimates, βˆ
(M)
k = Dˆ
(M)
k Y , the covariance of the estimates
may be approximated as
cov(βˆ
(M)
k ) ≈ σˆ2Dˆ(M)k (Dˆ(M)k )T ,
where σˆ2 is an estimate of the error variance. Based on this approximate covariance estimate, a
sensible way of defining the importance of the group k is by the following importance score for
the kth group,
τˆk =
1
pk
σˆ−2
(
βˆ
(M)
k
)T (
Dˆ
(M)
k (Dˆ
(M)
k )
T
)−1
βˆ
(M)
k , (4)
where a large value of τˆk would suggest that βk 6= 0, or the kth group is associated with the
phenotype. If the matrix
(
Dˆ
(M)
k (Dˆ
(M)
k )
T
)
is singular, we modify the definition of the importance
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score as the following: we first write
(
Dˆ
(M)
k (Dˆ
(M)
k )
T
)
= Udiag{λ1, . . . , λpk}UT ,
where λ1 ≥ λ2 . . . ≥ λpk are eigenvalues of
(
Dˆ
(M)
k (Dˆ
(M)
k )
T
)
and U is an orthogonal matrix. In
the singular case, assume the rank of
(
Dˆ
(M)
k (Dˆ
(M)
k )
T
)
is l(l < pk), then we use the following
matrix
Udiag
{
1
λ1
, . . . ,
1
λl
, 0, . . . , 0
}
UT ,
to replace
(
Dˆ
(M)
k (Dˆ
(M)
k )
T
)−1
in the formula (4).
4 Group Additive Accelerated Failure Time Models
We now consider the case when there is right-censoring on some of the observations yi. Suppose
that we have a random censoring time c, which is independent of the survival time y and the
covariates x. Let c1, · · · , cn be i.i.d. realizations of c. What is observed is an event-time ti =
min(yi, ci) and a censoring indicator δi = I{yi ≤ ci}, as well as the associated covariate xi.
The observed data are therefore {(ti, δi, xi) : i = 1, · · · , n}. The general accelerated failure time
(AFT) model (Wei, 1992) can be written as
g(ti) = F (xi) + ²i, i = 1, · · · , n
where g(·) is the known transformation function (e.g., log transformation), and F (xi) is defined
as in equation (2) or (3). To estimate the function F (xi), one can define a weighted loss function
by the inverse probability of censoring (Robins and Rotnitzky, 1992; van der Laan and Robins,
2002) as
l(F ) =
n∑
i=1
[
(g(ti)− F (xi))2 δi
Sˆ(ti)
]
=
∑
{1≤i≤n, δi=1}
[
(g(ti)− F (xi))2 1
Sˆ(ti)
]
, (5)
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where Sˆ(·) is the Kaplan-Meier estimate of the survival function for the censoring variable c.
More specifically, if the different elements of set {ti : 1 ≤ i ≤ n, δi = 0} are ordered as
t(1) < t(2) < . . . , < t(q),
then for each u ≥ 0, Sˆ(u) is defined by
Sˆ(u) =
∏
{k: t(k)≤u}
(
1− dk
nk
)
,
where dk is the number of observed censoring at time t(k), or the cardinality of set {i : 1 ≤
i ≤ n, ti = t(k), δi = 0}, nk is the number of individuals at risk of censoring at time t(k), or the
cardinality of set {i : 1 ≤ i ≤ n, ti ≥ t(k)}; when the set {k : t(k) ≤ u} is empty, define Sˆ(u) = 1.
Based on this weighted loss function (5), we can simply modify the previous algorithm by
replacing Uˆ
(m)
i with
Uˆ
(m)
i = −
∂l(F (x))
∂F (x)
|F (x)=Fm(xi),
and the least square fit of Xk to Uˆ
(m) with a weighted least square fit. In addition, in order to
obtain the closed form estimate of βk and the corrected AIC, we need to replace H(k) with
H(k) = X(k)((WX(k))
T (WX(k)))
−1(WX(k))TW,
where W is the n × n diagonal matrix with diagonal elements Wii = √wi, i = 1, · · · , n and
wi = δi/Sˆ(ti).
5 Simulation Studies
In this section, we present simulation studies to demonstrate the effectiveness of the proposed
G-GDBoosting procedure for fitting the GAR models. In all the examples, the learning rate
is fixed at ρ = 0.05. In addition, we also compare the results with those obtained using the
component-wise L2 boosting of Bu¨hlmann (2006).
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5.1 Description of the models for simulating the data
For all the following simulations, we simulate the x(i) from a uniform distribution [−0.5, 0.5], and
the error ²i from a normal distribution N(0, σ
2). We consider both low noise variance σ2 = 1 and
high noise variance σ2 = 4 and repeat all the simulations 200 times. We consider the following
four models with different degrees of complexity.
Model 1: For the first model, we assume that there is a total of 25 groups of genes, each including
four genes. We assume that the function in model (1) is generated based on the following GAR
model,
F (x) =
25∑
k=1
αTk x(k), x(k) = (x4(k−1)+1, . . . , x4k)
T ∈ R4, k = 1, . . . , 25,
where {αk, k = 1, . . . , 25} have the following values
(α1, α2, α3) =

1 −0.5 0.8
1.2 1.3 −1.4
−2 1.5 −1.6
3 2.6 2.7

, αk = 0, k = 4, . . . , 25.
This model implies that only the first three groups are related to the outcome y.
Model 2: The second model is similar to Model 1, except that each group has 10 instead of
only 4 genes, i.e., x = (x1, . . . , x250)
T ∈ R250, and we assume
F (x) =
25∑
k=1
βTk x(k), x(k) = (x10(k−1)+1, . . . , x10k)
T ∈ R10, k = 1, . . . , 25,
12
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where {βk, k = 1, . . . , 25} have the following values,
(β1, β2, β3) =

α1 α2 α3
0 0 0
...
...
...
0 0 0

, βk = 0, k = 4, . . . , 25.
Again, only the first three pathways are relevant. Different from Model 1, for the first three
groups, we assume that only 4 out of 10 genes are relevant to the outcome y.
Model 3: This model mimics the phenotype heterogeneity, where we assume that half of the
samples are generated from the following GAR model
F (x) = βT1 x(1) + β
T
2 x(2) + β
T
3 x(3)
and another half of the samples are generated from the following GAR model,
F (x) = βT1 x(4) + β
T
2 x(5) + β
T
3 x(6)
where {βk, k = 1, 2, 3} and {x(k), k = 1, . . . , 25} are the same as in Model 2. In this model, six
groups are relevant to the phenotype y.
Model 4: For model 4, we generate binary data y ∈ {−1, 1} from the following model,
log
(
P (y = 1|x)
P (y = −1|x)
)
= 0.5
10∑
j=1
xj
(
1 +
6∑
k=1
(−1)kx(k)
)
and assume that x = (x1, . . . , x100)
T ∈ R100. In our analysis, we divide the variables into 25
groups, each including four variables, {x(k−1)4+1, · · · , x(k−1)4+4} for the kth group. Different from
the previous three models, Model 4 does not have a simple linear form.
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5.2 Identification of the relevant groups
In the following simulations, a sample size of 100 was used for Model 1 and Model 2, 200 was
used for Model 3 and 300 was used for Model 4. Different sample sizes were used due to varying
complexity of the four models. Figure 1 shows the boxplots of the important scores based on the
G-GDBoosting procedure for each of the gene groups based on 200 replications for high noise
variance with σ2 = 4 (similar plots are observed for low noise cases with σ2 = 1). For each of
the four models, it is clear that the relevant gene groups have higher importance scores than
irrelevant gene groups. For Model 1, it is clear that the first three groups have much higher
importance scores than the others (see upper left plot). In fact, in the low noise case, in all
the 200 replications, the first three groups always have the highest importance scores. When
noise variance increases to σ2 = 4, the first three groups are simultaneously selected as the top
three groups in 82% of the replications. Similarly, for Model 2, the first three groups have much
higher importance scores than the others in both low and high noise cases (see upper right plot
of Figure 1). If the top three groups with the highest importance scores are selected, at least
2 and 3 out of the first three groups are simultaneously selected with probabilities of 100% and
99.5% in the low noise situation and 92.5% and 47.5% in the high noise case.
For Model 3, there are 6 gene groups or 24 genes that are related to the response. The bottom
left plot of Figure 1 shows that the first 6 groups have higher importance scores than the other
19 irrelevant groups. If the top six groups with the largest importance scores are selected, at
least 4, 5 and 6 groups out of the first 6 are simultaneously selected with probabilities of 94%,
67% and 9% in the low noise case and 53%, 16% and 2% in the high noise situation.
For Model 4, we generated 300 samples and repeated simulations 200 times. The lower right
plot of Figure 1 clearly shows that the first three groups have higher importance scores than the
others. Group 3 has smaller importance scores due to the fact that there are only two genes in
this group that are related to the outcome. If the top three groups with the highest importance
14
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scores are chosen, the probabilities that 1, 2 and 3 relevant groups are simultaneously selected
are 85%, 37.5% and 3%, respectively.
As a comparison, we also examined the behavior of the importance scores when the relevant
groups are not included in the analysis. We report here the results for models with noise variance
σ2 = 4; however, similar results are observed for σ2 = 1. Figure 2 shows the box plots of the
group importance scores over 200 simulations for the four different simulated models considered
when the gene groups in the analysis did not include the relevant groups. Clearly, no groups have
shown higher scores than others, indicating that no groups are more important to the phenotypes
than the others. This indicates that the importance scores can indeed be used for measuring the
importance of the groups to the phenotypes.
5.3 Comparison to component-wise boosting
As a comparison, we present the variable importance scores based on the component-wise gradient
descent boosting procedure of Bu¨hlmann (2006) in Figure 3. This procedure is a special case of
the G-GDBoosting procedure where each group includes only one variable. Comparing to Figure
1, we observe that signals as measured by the variable importance scores are not as clear as those
obtained for groups of variables using the proposed G-GDBoosting procedure. More specifically,
for Model 1, if the top 12 genes with the largest importance scores are selected, the probability
that at least 6, 8, 10 and 12 of the 12 relevant genes are selected among the top 12 genes are
99.5%, 87.5%, 33% and 0% respectively for the low noise variance models and 72.5%, 13.5%,
0% and 0% respectively for the high noise variances. For Model 2, if the top 12 genes with the
largest importance scores are selected, the probability that at least 6, 8, 10 and 12 of the 12
relevant genes are simultaneously selected are 96%, 61%, 4% and 0% respectively in low noise
variance models and become 28%, 2%, 0% and 0% respectively in high noise variance models.
For Model 3, if the top 24 genes with the largest importance scores are selected, the probabilities
15
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that at least 10, 12 and 16 out of the 24 relevant genes are simultaneously selected are 73%, 33%
and 0% respectively in low noise cases, but decrease to 7%, 3% and 0% respectively in high noise
case. Finally, for Model 4, if the top 10 genes with the largest importance scores are selected, the
probabilities that 4, 6 and 8 of the 10 relevant genes are simultaneously selected are 26%, 2% and
0% respectively for high noise variance models. These numbers, when compared with those based
on the G-GDBoosting method, clearly indicate that the component-wise boosting method does
not perform as well in selecting relevant variables. However, the chance of selecting the relevant
groups of genes is higher using the proposed G-GDBoosting procedure, further demonstrating
the advantage of using the group information when selecting the relevant groups of variables.
5.4 Prediction errors
In order to investigate the prediction performance of the G-GDBoosting procedure and to com-
pare the results with the component-wise boosting, for each model, we generated two sets of
training samples of the same sample size as in the previous section, one for low noise variance
and one for high noise variance. We then generated 500 new samples as the testing sets for
Models 1 and 2 and 1000 testing samples for Model 3. Let Fˆ (x) be the estimated function in
the GAR model (1) based on the training set; we then computed the mean square error (MSE)
as 1
m
∑m
i=1 |F (x(i)) − Fˆ (x(i))|2, where {yi, x(i)}mi=1 are the m testing samples. Table 1 presents
the MSEs for the simulated Models 1-3 and two noise variances using both component-wise and
group-wise boosting procedures. We observe that the G-GDBoosting procedure results in smaller
mean MSEs and also smaller variances of the MSEs, further indicating that the G-GDBoosting
method indeed provides better prediction than the component-wise GDBoosting.
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6 Applications to Real Data Sets
In this section, we present applications of the proposed methods to three real data sets, including
two breast cancer microarray gene expression data sets and one type 1 diabetes SNP data set.
6.1 Application to two breast cancer microarray gene expression data
sets
Miller et al. (2005) reported a gene expression profiling study of 251 primary breast cancer
tissues resected in Uppsala County, Sweden from January 1, 1987 to December 31, 1989, using
Affymetrix Chip HG-133A and HG-133B (GEO Accession No. GSE3494). The authors identified
an expression signature for p53 that can be used for predicting the mutation status, transcrip-
tional effects, and patient survival. Among these patients, 236 of them had follow-up information
in terms of time and event of disease-specific survival. The same 245 genes in 33 cancer-related
sub-pathways used in the previous example (see Table 2 for the pathways and the number of
genes in each pathway) were used in our analysis of this data set.
We applied the proposed group gradient descent boosting procedure with L2 penalized least
squares as weak learners for the AFT model and identified that the pathways related to Metal-
loendopeptidases (MMPs) and MMP inhibitors, as well as regulation of cell cycle, cell growth
and maintenance are important to breast cancer-specific survival. In fact, these three pathways
were the only pathways selected during the boosting procedure.
We also applied the method to another breast cancer gene expression data set as reported
in Sotiriou et al. (2006) (GEO Accession No. GSE2990), including gene expression data from
189 invasive breast carcinomas. Among these 189 patients, 88 of them are from the data set
of Miller et al. (2005), and 101 are patients from the John Radcliffe Hospital (Oxford, UK).
Treating the relapse-free survival time as the outcome in the AFT model, the G-GDBoosting
17
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procedure also identified the MMP pathway and the cell growth and maintenance pathway as
the two most important pathways related to breast cancer relapse. These two pathways were the
only pathways that were selected during the boosting procedure.
In summary, both data sets identified pathways related to MMPs and MMP inhibitors as
well as cell growth and maintenance as important pathways that are related to cancer-specific
survival. Miller’s data also suggest that the pathway related to cell cycle regulation may also
be related to breast cancer-specific survival. These pathways were also identified by Wei and
Li (2006) using a regression-tree-based boosting procedure. Involvement of these pathways in
breast cancer progression has been reported in the literature. The group of proteins of MMPs are
enzymes capable of degrading extracellular factors that surround a cell’s environment. MMPs can
directly cleave the matrix molecules that cells reside on, process growth factors to an active form,
and mediate cleavage of cell-bound proteins that are exposed on the outside of the cell. Certain
normal physiological processes require the action of these proteinases; however, dysregulation of
MMPs is often seen in many diseases, including breast cancer. In breast cancer and other cancers,
MMP dysregulation enhances tumor blood supply and their activity is necessary for many steps
involved in metastatic spread (Scorilas et al., 2001; Nakopoulou et al., 2003; Pellikainen et al.,
2004).
6.2 Application to type 1 diabetes SNP data set
We also applied the G-GDBoosting procedure to a type 1 diabetes data set reported by Clayton
et al. (2005), where they analyzed 6322 nonsynonymous SNPs (nsSNPs) in 816 cases of type
1 diabetes and 877 population-based controls from Great Britain. The nsSNPs are those SNPs
leading to an amino acid change in protein product, some are deleterious and some are neutral.
Our analysis focused on the nsSNPs on chromosome 6, since there are several known type 1
diabetes-related genes and loci. On chromosome 6, we have 644 nsSNPs that belong to 286
18
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genes. We used the additive coding for the genotypes. Figure 4 presents the relative importance
scores (normalized to the maximum of the scores) of the genes along chromosome 6. We found
that several genes in the HLA region are important to the development of type 1 diabetes, in
which the TAP2 (transport 2, ATP binding cassette) has the highest relative importance scores.
Other known T1 diabetes -related genes such as MICA, TNF and BAT2 also have relatively higher
importance scores. In addition, one gene close to the IDDM15 region also shows relatively high
importance scores. These results indicate that the G-boosting method can indeed identify genes
known to be associated with the risk of type 1 diabetes.
7 Conclusions and Discussion
In this paper we have proposed group additive regression models and a group gradient descent
boosting algorithm for identifying groups of variables that are related to the phenotypes of
interest. As demonstrated in our applications to analysis of microarray gene expression data,
these methods can be used for identifying groups of genes such as pathways that might be
related to the phenotypes. As the large body of biological information on various aspects of
the biological systems and pathways is available through databases or metadata, it is important
to utilize the information in modeling genomic data, especially in identifying genes and their
interactions and pathways that might be related to the phenotypes. The models proposed have
a natural biological interpretation as pathway activities when gene expression data are used or
genetic effects when SNPs data are used and can be applied to both continuous phenotypes and
censored survival phenotypes. Different from the traditional regression analysis, the proposed
methods naturally incorporate biological pathways or gene structures information. In addition,
our methods consider multiple groups simultaneously. Our simulation studies indicate that when
the variables can be appropriately grouped, our G-GDBoosting procedure results in smaller
predictive mean square errors than the component-wise gradient descent boosting.
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It is worth comparing our methods with some recent work on utilizing the group structures of
the data. An approach close to the proposed work is the average gene expressions for regression
method by Park et al. (2006) where they proposed a two-step procedure that combines hierarchi-
cal clustering and Lasso. By averaging the genes within the clusters obtained from hierarchical
clustering, they define super-genes and use them to fit regression models. This is essentially to
treat the clusters of genes as groups and use simple averages as weak learners. However, instead
of using boosting to select the groups, they use Lasso (Tibshirani, 1995). Yuan and Lin (2006)
recently proposed group-Lars and group-Lasso methods in order to select features as a group
among the predefined sets of variables rather than selecting a single term at a time as in the
original Lars (Efron et al., 2004) and Lasso methods (Tibshirani, 1995). Our G-GDBoosting
procedure can be regarded as an alternative way of selecting groups of variables. Besides the
applications presented in this paper, the G-GDBoosting procedure can also be applied to other
problems as presented in Yuan and Lin (2006).
There are several issues that deserve further study. First, it is important to study the sensitiv-
ity of the proposed methods to the misspecification of the groups information and misspecification
of the model. The first type of misspecification is that the genes included in the groups do not
really belong to the groups such as the pathways. However, this should not create a big problem
since these wrongly included genes should not be selected by the proposed methods. Another
type of misspecification is that the related genes are not included in the respected groups. The
third type of misspecification is that the relevant groups are not included in the model. However,
it should be noted that all types of regression analysis have such potential misspecification of
the models. Second, the ensemble methods have been proposed mainly for predictive purposes;
however, as demonstrated by Breiman (2001) and Friedman (2001) and also by our simulations,
these methods can also be used for identifying groups of variables that are relevant to the phe-
notypes. Although the relative importance scores used in this paper seem to perform well for
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identifying relevant variables, much future research needs to be done to rigorously investigate
the problem of defining variable importance in the setting of ensemble methods. For example,
important future research should assess the statistical significance of such importance scores, by
using bootstrap or permutations.
In summary, we have proposed a group additive regression framework for identifying pathways
and genes that are related to clinical phenotypes. The methods can be applied to both microarray
gene expression data in the context of pathway-based or gene set-based analysis and SNP data in
the context of gene-based association studies. The methods presented in this paper are especially
attractive in analysis of genome-wide association studies, where we can group the SNPs into
the respective genes and genes into the respective pathways. We are currently exploring such
applications.
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Table 1: Simulation results to compare the predictive performance as measured by the prediction
mean square errors (MSEs), mean, median and variance of MSEs based on 200 testing data sets
are presented for both component-wise gradient descent boosting (C-DGB) and group gradient
descent boosting (G-DGB).
Model 1 Model 2 Model 3
C-GDB G-GDB C-GDB G-GDB C-GDB G-GDB
σ2 = 1 Mean .85 .33 1.34 .82 2.55 2.40
Median .42 .18 .63 .35 1.19 1.12
Variance 1.14 .19 3.34 1.35 13.24 12.02
σ2 = 4 Mean 1.60 .57 5.91 2.23 3.97 2.84
Median .72 .25 2.87 .99 1.70 1.26
Variance 4.49 .58 65.42 8.75 34.92 17.60
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Table 2: Pathways considered in breast cancer data analysis, including the numbers of genes in
each pathway and a description of the pathways. The last set includes 188 genes that do not
belong to a particular pathway.
Pathway ID # of Genes Description
1 18 Anti-apoptosis
2 4 VHLCaspase activation
3 3 DNA damage response
4 24 Factors involved in other aspects of apoptosis
5 8 Induction of apoptosis
6 10 Induction of apoptosis by signals
7 6 Regulation of apoptosis
8 3 Apoptosis others
9 13 Cell cycle arrest
10 4 Cell cycle checkpoint
11 29 Factors involved in other aspect of cell cycle
12 81 Regulation of cell cycle
13 6 Cell differentiation/ cell fate determination
14 63 Cell growth and/or maintenance
15 41 Cell proliferation
16 11 Growth factors
17 46 Regulation of cell proliferation, differentiation, growth and volume
18 10 Cell migration and motility
19 2 Cell-cell adhesion
20 6 Cell-matrix adhesion
21 10 Metalloendopeptidases (MMPs) and MMP inhibitors
22 13 Cell surface receptor-linked signal transduction
23 9 Frizzled and frizzled-2 Signaling Pathways
24 17 G-protein coupled receptor protein signaling pathway
25 2 Insulin receptor signaling pathway
26 4 integrin-mediated signaling pathway
27 29 Intracellular signaling cascade
28 6 JAK-STAT cascade
29 2 Notch signaling pathway
30 3 RAS protein signal transduction
31 4 Rho protein signal transduction
32 13 Small GTPase mediated signal transduction
33 16 Wnt receptor signaling pathway
34 188 Other cancer-related genes
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Figure 1: Simulation results for models 1-4 with σ2 = 4: the boxplots of the variable importance
scores over 200 replications for each pathway based on the G-GDBoosting procedure. Top panel:
Models 1 and 2; bottom panel: Models 3 and 4.
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Figure 2: Simulation results for Models 1-4 with σ2 = 4: the boxplots of the variable importance
scores over 200 replications for each pathway based on the G-GDBoosting procedure when the
relevant pathways are not included in the analysis. Top panel: Models 1 and 2; bottom panel:
Models 3 and 4.
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Figure 3: Simulation results for Models 1-4 with σ2 = 4: the boxplots of the variable impor-
tance scores over 200 replications for each variable based on the component-wise gradient descent
boosting procedure. Top panels: Models 1 and 2; bottom panel: Models 3 and 4.
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Figure 4: Relative importance scores for genes on chromosome 6 for type 1 diabetes. IDDM1,
IDDM8 and DDM15 are the regions that were shown to be linked to type 1 diabetes by linkage
analysis.
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